Back

Drug therapy in adult congenital heart disease: the burden of polypharmacy

28 August 2018 (15:15 - 15:30)
Organised by:
Congress Presentation Part of: Drug therapy in congenital heart disease - What are the options and the needs? Epidemiology, Prognosis, Outcome ESC Premium Access ESC Congress 2018

About the speaker

Photo
Doctor Odilia Woudstra

Amsterdam University Medical Centre (AUMC), Amsterdam (Netherlands (The))

4 More presentations in this session

Presentation thumbnail
Thromboembolic prevention in adolescents and adults with Fontan circulation: Is ASS a therapeutical option in long-standing Fontan circulation?
Assistant Professor M. Westhoff-Bleck (Hannover, DE)
Abstract Slides Video
Presentation thumbnail
Thromboembolism and bleeding in adults with congenital heart disease using non-vitamin K antagonist oral anticoagulants for thromboembolic prevention: a prospective worldwide observational study
Miss H. Yang (Singapore, SG)
Abstract
Presentation thumbnail
Combination of fenestrated atrial septal occluder with targeted medical therapy in patients with secundum atrial septal defect and severe pulmonary arterial hypertension
Doctor C. Yan (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
Selective Heart Rate inhibition improves inadequate exercise response in Fontan Circulation
Mr B. Ruijsink (Utrecht, NL)
Abstract Slides Video

Access the full session

Session thumbnail
Drug therapy in congenital heart disease - What are the options and the needs?

The Event

Event poster

ESC Congress 2018

28 August 2018 15:15 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources